CHINNAIYAN ARUL M has a total of 29 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are MOLECULAR STAGING INC, FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST MOLEKULYARNOJ BIOLOGII IM V A ENGELGA and JURILAB LTD OY.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 18 | |
#2 | WIPO (World Intellectual Property Organization) | 11 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks | |
#6 | Environmental technology | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Chinnaiyan Arul M | 29 |
#2 | Yu Jindan | 5 |
#3 | Mehra Rohit | 5 |
#4 | Tomlins Scott A | 4 |
#5 | Tomlins Scott | 4 |
#6 | Mani Ram Shankar | 4 |
#7 | Sreekumar Arun | 3 |
#8 | Rhodes Daniel R | 3 |
#9 | Wang Xiaoju | 2 |
#10 | Dhanasekaran Saravana Mohan | 2 |
Publication | Filing date | Title |
---|---|---|
US2013225433A1 | Prostate cancer markers and uses thereof | |
US2013096021A1 | Recurrent gene fusions in breast cancer | |
US2012035244A1 | Parp1 targeted therapy | |
US2011207675A1 | Gene fusion targeted therapy | |
WO2010101994A2 | Gene fusion targeted therapy | |
US2009239221A1 | Recurrent gene fusions in prostate cancer | |
US2011028336A1 | MIPOL1-ETV1 gene rearrangements | |
WO2008058239A2 | Spink1 as a prostate cancer marker and uses thereof | |
WO2008060945A2 | Diagnosis and treatment of breast cancer |